These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 978463)

  • 1. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
    Keller KJ; Elliott GR; Holman RB; Vernikos-Danellis J; Barchas JD
    J Pharmacol Exp Ther; 1976 Sep; 198(3):619-25. PubMed ID: 978463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.
    Koe BK
    J Pharmacol Exp Ther; 1976 Dec; 199(3):649-61. PubMed ID: 994022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
    Wong DT; Threlkeld PG; Best KL; Bymaster FP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):61-5. PubMed ID: 6123593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of various tryptolines (tetrahydro-beta-carbolines) on 5-hydroxytryptamine receptors.
    Holman RB
    Prog Clin Biol Res; 1982; 90():167-81. PubMed ID: 6287489
    [No Abstract]   [Full Text] [Related]  

  • 7. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of tetrahydro-beta-carbolines with brain serotonin metabolism.
    Buckholtz NS
    Prog Clin Biol Res; 1982; 90():183-90. PubMed ID: 7111318
    [No Abstract]   [Full Text] [Related]  

  • 9. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of serotonin reuptake.
    Fuller RW; Wong DT
    Fed Proc; 1977 Jul; 36(8):2154-8. PubMed ID: 326579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 5-hydroxytryptamine uptake by tetrahydronorharmane in vivo.
    Rommelspacher H; Strauss S; Cohnitz CH
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):229-33. PubMed ID: 150545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites.
    Airaksinen MM; Mikkonen E
    Med Biol; 1980 Dec; 58(6):341-4. PubMed ID: 6112290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors.
    Schmidt MJ; Thornberry JF
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):42-51. PubMed ID: 201222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characteristics for inhibition of [3H] norepinephrine uptake into rat brain synaptic vesicles by beta-carboline, indolealkylamine, phenethylamine and n-alkylamine derivatives.
    Slotkin TA; Salvaggio M; Seidler FJ; Whitmore WL
    Mol Pharmacol; 1979 May; 15(3):607-19. PubMed ID: 492148
    [No Abstract]   [Full Text] [Related]  

  • 15. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 16. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
    Kihara T; Ikeda M
    J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat.
    Benfield DP; Luscombe DK
    Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake.
    Messing RB; Phebus L; Fisher LA; Lytle LD
    Psychopharmacol Commun; 1975; 1(5):511-21. PubMed ID: 132683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of ethanol intake by serotonin uptake inhibitors.
    Naranjo CA; Sellers EM; Lawrin MO
    J Clin Psychiatry; 1986 Apr; 47 Suppl():16-22. PubMed ID: 3007443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.